home / stock / bbi / bbi news


BBI News and Press, Brickell Biotech Inc. From 05/13/21

Stock Information

Company Name: Brickell Biotech Inc.
Stock Symbol: BBI
Market: NYSE

Menu

BBI BBI Quote BBI Short BBI News BBI Articles BBI Message Board
Get BBI Alerts

News, Short Squeeze, Breakout and More Instantly...

BBI - Brickell Biotech, Inc. (BBI) CEO Robert Brown on Q1 2021 Results - Earnings Call Transcript

Brickell Biotech, Inc. (BBI) Q1 2021 Earnings Conference Call May 13, 2021 16:30 ET Company Participants Garth Russell - Investor Relations, LifeSci Advisors Robert Brown - Chief Executive Officer Deepak Chadha - Chief R&D Officer Bert Marchio - Chief Financial Officer Conference Call Par...

BBI - Brickell Biotech EPS misses by $0.03

Brickell Biotech (BBI): Q1 GAAP EPS of -$0.15 misses by $0.03.Strengthened the Company’s balance sheet to $34.8 million in cash and cash equivalents at the end of the first quarter of 2021, which includes aggregate net proceeds of $10.6 million from warrant exercises and the ...

BBI - Brickell Biotech Reports First Quarter 2021 Financial Results and Provides Corporate Update

Completed enrollment in Phase 3 pivotal Cardigan I study and exceeded 70% enrollment in Phase 3 pivotal Cardigan II study - - - Topline results for Phase 3 pivotal Cardigan I and Cardigan II studies expected in Q4 2021 - - - Presented results from Phase 3 open-labe...

BBI - Brickell Biotech Advances To Phase III As It Eyes Commercialization

Brickell Biotech is conducting two important phase III studies of its investigational drug to treat excessive sweating. These studies, CARDIGAN I and II, should produce topline results later in 2021. Eli Lilly already has a medication approved in this space, limiting the drug's re...

BBI - Brickell Biotech to Report First Quarter 2021 Financial Results and Provide a Corporate Update on May 13, 2021

BOULDER, Colo., April 29, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today an...

BBI - Brickell Biotech completes patient enrollment in late-stage sweat disorder study

Brickell Biotech (BBI) announces the completion of patient enrollment in the Phase 3 pivotal Cardigan I study evaluating sofpironium bromide gel, 15% in patients with primary axillary (underarm) hyperhidrosis.Shares up more than 2% premarket.Hyperhidrosis is a debilitating cond...

BBI - Brickell Biotech Completes Patient Enrollment in U.S. Phase 3 Pivotal Cardigan I Study of Sofpironium Bromide Gel, 15% for the Treatment of Primary Axillary Hyperhidrosis

Phase 3 Pivotal Cardigan II study exceeds 50% enrollment - - - Topline results for Phase 3 Pivotal Cardigan I and Cardigan II clinical studies expected in Q4 2021 BOULDER, Colo., April 27, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the &...

BBI - 4 Reddit Penny Stocks To Buy On Robinhood For Under $1 Right Now

Should These Be On Your List Of Penny Stocks To Buy? Trading penny stocks is simple in theory. You find cheap shares, hit the buy button on your broker platform, then sell when your profit target is reached. However, when it comes to finding the top penny stocks to buy, a lot more e...

BBI - Biotech Penny Stocks To Buy? 3 to Watch Under $5

Are These Biotech Penny Stocks on Your Watchlist? As April comes to an end, investors are still searching for the best penny stocks to buy . Whether due to the pandemic or not, 2021 has been the year for biotech penny stocks . While Covid had a negative impact on most industries...

BBI - Brickell Biotech Reports Results from U.S. Phase 3 Open-Label, Long-Term Safety Study on Chronic Use of Sofpironium Bromide Gel as a Potential Treatment for Primary Axillary Hyperhidrosis

Daily treatment with sofpironium bromide gel was generally well-tolerated over 48 weeks of treatment Efficacy assessments showed a clinically meaningful and sustained improvement in sweat severity through the 48 weeks of treatment Data presented today in a late-breaking ...

Previous 10 Next 10